Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supplyMarch 30, 2026
The cobas MPX-E test provides four critical results (for HIV, HCV, HBV, and HEV) in a single test, i...
Publisher
Switzerland
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The cobas MPX-E test provides four critical results (for HIV, HCV, HBV, and HEV) in a single test, i...
Source route
Continue on roche.com
Leave the platform to read the original full article on the publisher site.
Source: Roche Diagnostics News
Scope: Devices
Related coverage
More related coverage
Butterfly Network strikes US first with POCUS gestational age tool clearance
Butterfly’s GA tool within its point-of-care ultrasound (POCUS) system is intended for rollout in re...
Culture in Action: What Makes Fortrea, Fortrea
Roche unveils cobas MPX-E assay for HIV and hepatitis viruses
Roche has launched the cobas MPX-E donor screening assay for detecting and differentiating HIV 1 and...
FDA clears Medtronic’s Stealth Axis system for cranial and ENT procedures
Medtronic views Stealth Axis as the ‘cornerstone’ of AiBLE, the company’s surgical workflow ecosyste...